The global Hepatitis B Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.Hepatitis B is a viral infection caused by a hepatitis B virus.

The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more.

Global Hepatitis B Treatment Market: Competitive LandscapeSome of the key players in the global Hepatitis B Treatment Market areAccord Healthcare Inc.Apotex Corp.Arbutus BiopharmaArrowhead PharmaAurobindo Pharma LimitedBristol-Myers Squibb CompanyGilead Sciences, Inc.GlaxoSmithKlineLupin Pharmaceuticals, Inc.Merck & Co., Inc.Par Pharmaceutical, Inc.Teva PharmaceuticalsZydus PharmaceuticalsHepatitis B Treatment Market SegmentationThe global Hepatitis B Treatment Market is segmented on the basis of type, treatment, distribution channel, and region.Based on type, the market is segmented into acute and chronic.

Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth.

Asia Pacific was the fastest growing region for the global Hepatitis B Treatment Marketin 2017.

On the other hand, the Middle East and Africa holds the least share in the global Hepatitis B Treatment Market market.

It is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market.

On the other hand, the restricted access to systems in emerging countries is expected to hamper the growth of the market.Segmentation:The global medical terminology software market is segmented on the basis of product & service, application, and end user.The medical terminology software market, by product & service, is categorized into services and platforms.Based on application, the medical terminology software market is segmented into data aggregation, reimbursement, public health surveillance, data integration, decision support, clinical trials, quality reporting, and clinical guidelines.On the basis of end user, the market is segmented into healthcare providers, healthcare payers, and healthcare IT vendors.

The healthcare payer’s subcategory is further divided into private payers and public payersKey Players:Some of the key players in the global medical terminology software market areWolters Kluwer3MIntelligent Medical ObjectsApelonClinical ArchitectureCareComBitacB2i HealthcareBT Clinical Computingand HiveWorxMedical Terminology Software Market: HighlightsIt is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market.

For instance, in 2016, Wolters Kluwer (Netherlands) announced a partnership with HealthCore, Inc., (US), a clinical outcomes research subsidiary of Anthem, Inc. (US), to provide data normalization services to the California Integrated Data Exchange through its health language enterprise terminology management platform.

This initiative is anticipated to open new avenues for the firm to cater to the untapped markets in this region.Browse Complete 160 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/medical-terminology-software-market-7785Regional Analysis:The Americas is expected to hold a major share in the global medical terminology software market can be attributed to the growing demand for accurate data exchange between healthcare providers and payers to streamline workflows in the region.Europe is expected to hold the second largest share in the medical terminology software market due to the increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years.Asia-Pacific was projected to be the fastest growing region for the global medical terminology software market due to the high adoption of HCIT technologies, regulatory requirements regarding patient safety.

The Middle East and Africa holds the least share in the market due to fewer initiatives taken by the government.Table Of ContentsChapter 1.

The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.

Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.

According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years.

However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.Global Opioids Market: Competitive LandscapeSome of the key players in the global Opioids Market areMallinckrodt (Surrey)Vertice Pharma LLC (UK)Janssen Global Services, LLC (US)Egalet Corporation (US)Sun Pharmaceutical Industries Ltd (India)West-Ward Pharmaceuticals Corporation (Jordan)Purdue Pharma L.P. (US)Allergan Inc. (US)Teva Pharmaceutical Industries Ltd (Israel)Boehringer Ingelheim GmbH (Germany)Sanofi SA (France), Pfizer Inc. (US)Opioids Market SegmentationThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.

The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.

On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.Opioids Market Regional AnalysisThe Americas is expected to hold the largest share of the global opioids market.

The Global Autoinjectors Market is Estimated to be Valued at USD 79,741 Million by 2024 and is Expected to Register aCAGR of 17.42% During the Forecast Period.The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Millionby the end of 2024.

Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024.Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60%during the forecast period.

Global Autoinjectors Market: Competitive LandscapeSome of the key players in the global Autoinjectors Market areAmgen Inc. (US)Becton, Dickinson and Company (US)AbbVie Inc. (US)Mylan N.V. (US)Eli Lilly and Company (US)Ypsomed (Switzerland)Owen Mumford Ltd (UK)Consort Medical (UK)SHL Group (Taiwan)Johnson & Johnson Services Inc. (US)Teva Pharmaceutical Industries Ltd (Israel)Antares Pharma (US)Autoinjectors Market SegmentationThe Global Autoinjectors Market has been segmented on the basis of product type, design therapeutic application, distribution channel, and region.

The disposable autoinjectors segment held the majority market share in 2018.

It also was the fastest-growing owing to the increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors.Autoinjectors Market Regional AnalysisGeographically, the global autoinjectors market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.

The well-established healthcare infrastructure, technology advancement, and innovation in drug delivery systems, and rising prevalence of anaphylaxis incidences, diabetes, and cancer are driving the growth of the autoinjectors market in the region.

The Global Soft Tissue Repair Market is expected to grow significantly over the forecast period.

It is anticipated that the market held a valuation of USD 5200 million in 2017 and is projected to register a CAGR of 6.2% over the forecast period.The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market.

The xenograft implant is designed for the surgical repair of damaged or ruptured membranes.Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.SegmentationThe global soft tissue repair market is segmented based on product, application, end user, and region.the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others.

The biological segment includes allograft and xenograft.Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.The European soft tissue repair market has been segmented into Western Europe and Eastern Europe.

Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth.

The market for the global dental industry is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.Global Dental Industry Market: Competitive LandscapeSome of the key players in the global Dental Industry Market areHenry Schein Inc.Hu-Friedy Mfg Co.Ivoclar Vivadent AGNakanishi Inc., Patterson Companies Inc.Dentsply SironaUltradent Products Inc.Young Innovations Inc.3M CompanyZimmer BiometKangda MedicalDental Industry Market SegmentationThe global dental industry market is segmented on the basis of discipline, consumables and end users.

On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies.

The North American region is likely to hold the major share in the global dental industry market owing to the presence of well-established healthcare sector, growing prevalence of dental problems and also high disposable income.

Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to the rising awareness about treatment and increasing healthcare facilities provides a favourable scenario for market growth.Dental Industry Market Regional AnalysisThe Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas.

According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others.

The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes.

Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions.However, factors such as lack of trained medical professionals is expected to curb the growth of the market during the forecast period.On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period.

The North American region holds substantial share in the global market.This owes to the growth of federal healthcare regulations that curb the rising healthcare costs; rising government initiatives focusing on personalized medicine, growing EHR adoption; and population health management.It Is Estimated That the Global Healthcare Predictive Analytics Market Is Expected To Register A CAGR ~29.3% During the Forecast Period Of 2018–2023.Currently, the global healthcare predictive analytics market is dominated by numerous players.

The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio.

For example, in August 2018, Verscend Technology acquired Cotiviti Holdings, Inc., a leading provider of payment accuracy and analytics-driven solutions focused primarily on the healthcare industry.

Also, in July 2018, Health Catalyst acquired Medicity, a PHM company offering solutions for HIEs, business intelligence, and provider and patient engagement.Key PlayersSome Of The Key Players In The Global Intraocular Lens Market Are IBM Corporation (US), Optum, Inc. (US), Cerner Corporation (US), SAS Institute, Inc. (US), Allscripts Health Solutions (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Inovalon (US), Oracle Corporation (US), Health Catalyst (US), SCIO Health Analytics (US), Verscend Technologies, Inc. (US), CitiusTech, Inc. (US), Wipro Limited (India), and VitreosHealth (US).SegmentationThe global healthcare predictive analytics market is segmented on the basis of component, application, and end user.For instance, IBM invests a significant amount of its revenue in research activities to continuously improve its product portfolio.

Tele-intensive care unit (ICU) are used for the management of various medical complications and to treat critically ill patients by using off-site clinical resources.

Tele-intensive care units (ICU) are part of telemedicine, and it uses advanced technology to carry out activities such as monitoring, treatment, and rehabilitation.The rising geriatric population, technological advancements in the healthcare sector, increasing occurrence of chronic disorders in the developed and developing countries, and increasing cases of patients affected by neurological disorders across the globe are the major factors driving the growth of the global tele-intensive care unit (ICU) market.

Additionally, increasing R spending and aggressive strategies adopted by the top players are fueling the growth of the market during the forecast period.

According to the World Health Organization and International Agency for Research on Cancer (IARC) reported that in 2018, there were 18.1 million new cases of cancer which is projected to reach 43.8 million over the next five years.

The rising worldwide prevalence of cancer is propelling the demand for tele-intensive care unit (ICU), thereby supporting market growth.The high costs associated with establishments of tele-intensive care unit (ICU) and lack of reimbursement policy are likely to hinder the market growth during the forecast period.Global Tele-Intensive Care Unit (ICU) Market: Competitive LandscapeSome of the key players in the global Tele-Intensive Care Unit (ICU) Market areIntouch Technologies, Inc.SOC TelemedAdvanced Icu CareUPMCBanner HealthTeleicucareKoninklijke Philips N.V.Eagle TelemedicineApollo TeleHealth ServicesTele-Intensive Care Unit (ICU) Market SegmentationThe global tele-intensive care unit (ICU) market has been classified on the basis of component and type of management.Based on component, the market has been classified as hardware and software.

The market, by hardware, has been further segmented into computer system, communication lines, physiological monitors, therapeutic devices, video feeds, and others.On the basis of management, the market has been segmented into intensivist, open, co-managed, open with a consultant, and other types of management.Tele-Intensive Care Unit (ICU) Market Regional AnalysisThe Americas are likely to dominate the global Tele-Intensive Care Unit (ICU) market owing to the technological advancements related to healthcare, rising cases of chronic disorders, and an increasing number of hospitals in the regions.

In healthcare industry clinical trials are performed for medicine, medical devices which includes hearing aid and surgical procedure.The key factors driving the clinical trial industry includes rising prevalence of diseases, high R expenditure of the pharmaceutical industry, and growth of new treatments such as personalized medicine is supporting to grow the market.

However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.The market for global clinical trial market is estimated to grow at an approximate CAGR of 5.7% from 2017 to 2023However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.Key Players:Charles River Laboratories, Paraxel International Corporation, Quintiles IMS, ICON plc, SGS SA, Eli Lilly and Company, Novo Nordisk A/S, Clinipace, Laboratory Corporation of America, Pfizer and Others are some of the major players for global clinical trials market.Segmentation:The global clinical trials market is segmented on the basis of phase, study design, indication and end users.

On the basis of study design, the global clinical trials market is segmented into interventional, observational and expanded access.

On the basis of indication, the global clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, central nervous system (CNS) condition, diabetes, obesity, cardiovascular and others.

The North American region is likely to hold the major share in the global clinical trial market owing to the presence of well-established healthcare sector, growing prevalence of high diseases and also increasing funding from government.

Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to increasing geriatric population with either one or more disease and favorable environment such as low operating cost, skilled technician and increasing healthcare facilities provides favorable scenario for the market growth.Regional Analysis:The Americas dominate the global  clinical trial market owing to the presence of major pharmaceutical and biotech companies with R units in America and increasing patient population suffering from cardiac problem boost the clinical trial market in this region.

The global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors.

The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times.

Global Healthcare Information Systems Market: Competitive LandscapeSome of the key players in the global healthcare information systems market areAgfa-Gevaert N.V.Allscripts Healthcare Solutions Inc.Athenahealth Inc.Carestream HealthCerner CorporationGE HealthcareMcKesson CorporationMedidata Solutions Inc.NextGen HealthcarePhilips HealthcareSiemens HealthineersHealthcare Information Systems Market SegmentationThe global healthcare information systems market is segmented based on type, components, deployment, end user, and region.On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management.

The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.Healthcare Information Systems Market Regional AnalysisThe Americas leads the global healthcare information systems market.

Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure.

Dental biomaterials are fabricated/natural structures used in dentistry.

The rising prevalence of dental caries and increasing incidences of dental trauma produces developmental backgrounds for the global dental biomaterials market.

Developing countries like India are becoming a global spot for dental tourists.

This can be attributed due to the cheap and quality dental services provided within the country.A study published by the Journal of Clinical and Diagnostic Research in 2016, stated that in India a typical dental implant costs about USD 600 in comparison to USD 2,000 and 1070 for US and Hungary, respectively.

Key PlayersSome of the key players in the global dental biomaterials market are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc. , Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd, Medtronic PLC, Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, Bego Medical GmbH, Cam Bioceramics B.V., and others.SegmentationThe global dental biomaterials market is segmented on the basis of type, application, and end user.Based on type, the market is segmented into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials.

The metallic biomaterials segment is further divided into titanium, stainless steel, and chromium alloys, and others.The application segment is sub-segmented into implantology, prosthodontics, orthodontics, others.The end user segment is divided into dental product manufacturers, dental laboratories, dental hospitals and clinics, dental academies, and research institutes.Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/dental-biomaterials-market-7526Regional AnalysisThe Americas dominates the global market for dental biomaterials.

Orthobiologics are derived from the human body and used by surgeons for treating injuries.

It helps in easy recovery and healing of wounds.

The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period.Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market.

According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US.

Also, 24.5% of women 65 years of age and over have a lumbar spine in US.The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.Global Orthobiologics Market: Competitive LandscapeSome of the key players in the global Orthobiologics Market areArthrex, Inc.Exactech, Inc.Globus Medical Inc.Integra LifeSciencesJohnson & JohnsonMedline Industries, Inc.NuVasive, Inc.Stryker CorporationWright Medical Group N.V.Zimmer BiometOrthobiologics Market SegmentationThe global orthobiologics market has been segmented on the basis of product, application, end-user, and region.Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.Orthobiologics Market Regional AnalysisThe market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market.

The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.Table Of Content1.

The global aortic aneurysm market held a market value of USD 2,357.6 million in 2017 and is projected to grow at a CAGR of 8.4% over the forecast period.

An aortic aneurysm is an abnormal enlargement or bulging of the wall of the aorta.

Aortic aneurysm has two types such as an abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA).

An abdominal aortic aneurysm is an aneurysm in the part of the aorta that passes through the abdomen while thoracic aortic aneurysm is an aortic aneurysm that presents mainly in the thorax.Some of the market growth factors include rising prevalence of tobacco smoking in the developed and developing countries, worldwide growing elderly population coupled with the increasing burden of cardiovascular diseases, favorable reimbursement scenarios for surgical treatment of aortic aneurysms, and mounting technological advancements in products.

In contrast, the presence of low reimbursement rates in the developing countries and higher cost of aortic aneurysm treatment and devices are anticipated to hinder the market growth during the next five years.SegmentationThe global aortic aneurysm market has been segmented into type, product, treatment, end user, and region.By type, the market has been segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA).On the basis of product, the market has been divided into stent-grafts, catheters, and others.By treatment, the market has been classified into endovascular aneurysm repair (EVAR) and open surgical repair (OSR).Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.Key PlayersSome of the spearheading players in the global aortic aneurysm market areMedtronic plcCook MedicalTerumo Medical CorporationMicroport Scientific CorporationMAQUET Holding B.V. & Co. KGEndologix Inc.L.

For instance, in 2015, Cook Group Incorporated launched its Zenith Alpha abdominal endovascular graft in Canada.Europe would be the second-largest value contributor in the aortic aneurysm market due to the highest prevalence of tobacco smoking and the presence of favorable initiatives by several organizations to reduce the burden of aortic aneurysm.

Global Orphan Drugs Market - SynopsisOrphan drugs are generally used for treating rare disorders and diseases that affect a small percentage of the population.

There are approximately 30 million in Europe, 30 million people in the US, and 350 million people worldwide who suffer from 7,000 types of rare diseases.Disorders among which four-fifths of the rare diseases are genetic and 50 % of the crowd affected being children.

Only 5 % of the rare diseases had approved drug treatment with 326 new drugs being approved by FDA and brought to the market.Competition Analysis:                                                                                     The key players operating the orphan drugs market are Alexion Pharmaceuticals Inc., Bayer AG, Sanofi, Celgene Corporation, Novartis AG, Biogen Idec Limited, Hoffmann- La Roche, Takeda Pharmaceuticals Company Limited, Bristol-Myers Squibb, Vertex Pharmaceuticals Inc. Johnson & Johnson, and others.Segmentation Analysis:Globally, the market for orphan drugs has been segmented on the basis of application, pharmacological class, source, technology, and region.The market has been segmented into enzyme replacement, protein replacement, and gene chromosome expression based on pharmacological class.The market has been segmented into oncology, blood-related disorders, neurology, nephrology, and infectious diseases based on applications.

Among these, oncology is predicted to dominate the market owing to the increasing drug approvals for treating rare cancers.The market has been segmented into Transgenic, DNA recombination, and gene expression based on technology.The market has also been segmented into biological orphan drug and non-biological orphan drug based on source.

Among these, biological orphan drug leads the market in terms of revenue and is predicted to maintain its dominance over the assessment period owing to the high efficacy of biologic products for treating diseases.Future Drivers and Constraints Affecting the Market                               Growing investment in R, unmet requirement for rare diseases, economic, legislative, and tax benefits offered by the government, high ROI, development of latest technologies like hybridoma, gene mapping, and DNA recombinant, extensive exclusivity, and faster uptake and low marketing cost are some of the major factors driving the market over the forecast period.There has been a growing demand for drugs for rare diseases such as Yellow Fever, Von Willebrand Disease, Aarskog Syndrome, Waardenburg Syndrome, diabetic macular edema, Abetalipoproteinemia, Autism spectrum disorder (ASD), Yellow Nail syndrome, Asperger syndrome, Von Hippel-Lindau Disease, and others which is contributing towards the growth of the market.

Moreover, FDA free waivers, R grants by the government, favorable reimbursement policy along with premium pricing owing to the low competition also contribute the market growth.

The Global Medical Marijuana Market is expected to register a CAGR of 34.0% to reach USD 54,677.1 Million by 2023.Marijuana is a plant having some chemical compound “cannabis” that has medical property.

Marijuana plants extracts are used to treat the disease and various conditions caused by the disease such as the central nervous system, cancer, Alzheimer’s and used in anti-aging products.The rising prevalence of chronic diseases, growing therapeutic applications of the marijuana plant, growing acceptance of marijuana for medical treatment in many countries, and increasing the authorization of marijuana are anticipated to drive the market growth.The American accounts the largest market share in 2017.

Global Medical Marijuana Market: Competitive LandscapeSome of the key players in the global Medical Marijuana Market areCanopy Growth Corporation (US)Cannabis Sativa Inc (Nevada)GW Pharmaceuticals Plc (US)Emerald Health Therapeutics Inc. (Victoria, BC)Tilray (Nanaimo, BC)Aphria (Ontario)CanniMed Ltd (Canada)Cara Therapeutics (US)Pfizer Inc. (US)Medical Marijuana Inc(US)GBSciences Inc.( Nevada)MediPharm Labs(US)Medical Marijuana Market SegmentationThe global medical marijuana market is segmented into product type, application, and distribution channel.

On the basis of product type, the market is segmented into solids, dissolvable/powders, oil, and ointments & creams.

The dissolvable/powders segment is expected to lead the market and register a substantial CAGR to reach USD 22,648.8 million by the end of 2023.

On the basis of distribution channel, the market is segmented into retail & pharmacy stores, online platforms, and others.Medical Marijuana Market Regional AnalysisGeographically, the global medical marijuana market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.

The global endodontic devices market is expected to register an approximate CAGR of 5.34% during forecast period, 2018–2023.Endodontics is a part of dentistry which deals with the study and treatment of the dental tissue.

Endodontic treatment is also called root canal treatment which involves the diagnosis, prevention, and treatment of illnesses and injuries of the dental pulp.

The major key factors contributing to driving this market are increasing prevalence of the dental problem, microbial infected tooth, rising aging population and increasing incidence of oral cavity cancer among the population.However, the factors such as high cost of treatment, illegal sales of dental products and complications related to treatments may hamper the market growth during the forecasted period.Global Endodontic Devices Market: Competitive LandscapeSome of the key players in the global Endodontic Devices Market areDENTSPLY SIRONADanaher CorporationIvoclar VivadentUltradent ProductsSeptodont, Brasseler USAMICRO-MEGADiaDent Group InternationalCOLTENE HoldingKerr CorporationSurtex Instruments LimitedDavis Schottlander & Davis LtdHu-Friedy Mfg.

Co., LLCEndodontic Devices Market SegmentationThe global endodontic devices market is segmented on the basis of product, end user, and region.On the basis of product, the global endodontic devices market is segmented into consumables and instruments.By consumables, the global endodontic devices market is categorized into endodontic burs, endodontic files & shaper, irrigating solution & lubricants, obturation filling materials and others.By instruments, the market is further sub-segmented into apex locators, endodontic scalers, machine-assisted obturation systems, handpieces, and endodontic lasers.

By end-user, the global endodontic devices market is categorized into dental clinics, dental hospitals, laboratories, dental academic and research institutes.On the bases of region, the global endodontic devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

In 2017, it was estimated that Europe stood second in the global endodontic devices market due to the rising demand for root canal treatment and increasing microbial infection in teeth in boosts the market growth.